Keyphrases
Hepatitis C Treatment
73%
People Who Inject Drugs
70%
Hepatitis C Virus
62%
Baltimore
50%
People Living with HIV (PLHIV)
36%
Hepatitis C
29%
Treatment Uptake
23%
Confidence Interval
21%
Direct-acting Antivirals
19%
Hepatitis C Virus Infection
19%
Social Networks
17%
Network Member
16%
Sustained Virological Response
16%
AIDS/HIV
15%
Maryland
15%
Hepatitis C Virus Screening
14%
Substance Use Disorder
11%
Adjusted Odds Ratio
11%
Drug Use
11%
Treatment Initiation
11%
Injection Drug Use
11%
Hepatitis C Testing
10%
Hazardous Drinking
10%
Alcohol Use
10%
Substance Use
10%
Continuum of Care
9%
Linkage to Care
9%
Reinfection
8%
Non-fatal Overdose
8%
Viral Non-suppression
8%
HIV Care
8%
Social Support
7%
Viremia
7%
Cocaine
7%
Women Who Inject Drugs
7%
Virus
6%
Illicit Drugs
6%
Incidence Rate
6%
Johns Hopkins
6%
COVID-19
6%
Drug Overdose
6%
Negatively Associated
5%
Antiretroviral Therapy
5%
HIV Treatment
5%
Hepatitis C Virus RNA
5%
United States
5%
Patient Navigation
5%
Baltimore City
5%
Black Race
5%
Overdose Risk
5%
Medicine and Dentistry
Hepatitis C Virus
100%
Human Immunodeficiency Virus
71%
Hepatitis C
59%
Drug Use
28%
Hepatitis C Treatment
21%
Antivirus Agent
20%
Alcohol Consumption
19%
Infection
14%
Substance Use Disorder
12%
Odds Ratio
12%
Gene Linkage
11%
Chronic Hepatitis C
11%
Public Health
9%
Liver Disease
8%
Antiretroviral Therapy
8%
Social Network
8%
Human Immunodeficiency Virus Infection
8%
Substance Use
7%
Opiate
7%
Hepacivirus
7%
Prevalence
6%
Cohort Analysis
6%
Chronic Hepatitis B
6%
Illicit Drug
5%
Mental Health Care
5%
Combination Therapy
5%
Primary Health Care
5%
Outpatient
5%
Hepatitis B
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C Virus
75%
Hepatitis C
66%
HIV
57%
Antivirus Agent
23%
Ethanol
16%
Opiate
13%
Infection
12%
Toxic Injury
12%
Disease
11%
Chronic Hepatitis C
10%
Liver Disease
8%
Reinfection
8%
Virus Hepatitis
7%
Randomized Controlled Trial
7%
Hepacivirus
7%
Mixed Infection
7%
Drug Dependence
6%
Ledipasvir Plus Sofosbuvir
6%
Elimination
5%
Cohort Study
5%
